Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls

Table 3

Characteristics of control group.

	Control + NAFLD	Control − NAFLD	Whole group (control)
GOT (U/L)	20.08 ± 7.63	18.95 ± 3.95	19.51 ± 6.06
GPT (U/L)	20.23 ± 11.54	17.19 ± 7.47	18.70 ± 9.79
GGTP (U/L)	21.03 ± 9.45	17.76 ± 5.59	19.38 ± 7.89
Bilirubin (mg/dL)	2.605 ± 0.51	1.325 ± 0.78	1.97 ± 0.66
Triglycerides (mg/dL)	83.39 ± 53.37	71.63 ± 27.21	77.51 ± 42.60
Total cholesterol (mg/dL)	181.70 ± 37.33	184.20 ± 39.03	183.00 ± 38.09
LDL cholesterol (mg/dL)	108.60 ± 37.18	106.60 ± 31.34	107.60 ± 34.26
HDL cholesterol (mg/dL)	66.02 ± 21.72	66.65 ± 14.83	66.33 ± 18.52
Mean glucose level (mg/L)	101.2 ± 19.53	95.8 ± 16.63	98.4 ± 18.25
Mean insulin level (𝜇IU/mL)	40.58 ± 35.71	32.82 ± 21.95	36.67 ± 29.72
Testosterone (ng/mL)	0.397 ± 0.154	0.368 ± 0.163	0.382 ± 0.159
SHBG (mmol/L)	49.87 ± 30.17	58.66 ± 25.99	54.48 ± 28.28
FAI value	3.99 ± 3.33	2.55 ± 1.63	3.23 ± 2.67

Data are presented as mean ± SD.